4Van Staa T, Abenhaim L, Monette J, et al. Rates of hypoglycemia in users of sulfonylureas[J]. J Clin Epidemiol, 1997, 50(6): 735-741.
5UKPDS-33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group[J]. Lancet, 1998, 52(9131 ): 837-853.
6Shorr RI, Ray WA, Daugherty JR, et al. Individual sulfonylureas and serious hypoglycemia in older people[J]. J Am Geriatr Soc, 1996, 44(7): 751-755.
7Gangji AS, Cukierman T, Gerstein HC, et al. Systematic review and meta- analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin[J]. Diabetes Care, 2007, 30(2): 389-394.
8Fravel MA, McDanel DL, Ross MB, et al. Special considerations for treatment of type 2 diabetes mellitus in the elderly[J]. Am J Health Syst Pharm, 2011, 68(6): 500-509.
9Riddle MC, McDaniel PA, Tive LA. Glipizide-GITS does not increase the hypoglycemie effect of mild exercise during fasting in NIDDM[J]. Diabetes Care, 1997, 20(6): 992-994.
10Schernthaner G, Grimaldi A, Di Mario U, et al. GUIDE study: double- blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients[J]. Eur J Clin Invest, 2004, 3(8): 535-542.
